Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-21

Clinical Trial Update: Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the effect of Gemfibrozil on serum GPI phospholipase D and triglycerides in individuals with hypertriglyceridemia; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Lopid) (Gemfibrozil)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Hypertriglyceridemia | Phase 1 | Status: COMPLETED